Oxeia Biopharmaceuticals: Funding, Investors & Team (Oct 2026)
Oxeia Biopharmaceutical soperates in the healthcare industry focusing on pharmaceutical business. According to the Centers for Disease Control, 2.2 million cases of mild traumatic brain injury (concussions) are seen in US hospital emergency rooms every year. Other estimates suggest 4 – 5 million concussions to be more accurate if unreported events are also considered. Research in the last two decades has increasingly linked concussions to neurodegenerative conditions including dementia, Alzheimer’s disease, and chronic traumatic encephalopathy (CTE).
Oxeia Biopharmaceuticals has raised $1.4M across 1 funding round on record, the most recent an undisclosed round of $1.4M announced in Apr 2026.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Oxeia Biopharmaceuticals Company Profile and Key Stats
Latest funding round on record: Apr 2026.
Oxeia Biopharmaceuticals Funding Rounds
Oxeia Biopharmaceuticals Founders and Leadership Team
No contact details are on record for this team yet.
Oxeia Biopharmaceuticals Funding Compared to Other Biotechnology Startups
Oxeia Biopharmaceuticals' latest round of $1.4M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Oxeia Biopharmaceuticals in Biotechnology and San Diego
Companies Similar to Oxeia Biopharmaceuticals
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Oxeia Biopharmaceuticals Funding FAQs
What does Oxeia Biopharmaceuticals do?
Oxeia Biopharmaceutical soperates in the healthcare industry focusing on pharmaceutical business. According to the Centers for Disease Control, 2.2 million cases of mild traumatic brain injury (concussions) are seen in US hospital emergency rooms every year. Other estimates suggest 4 – 5 million concussions to be more accurate if unreported events are also considered. Research in the last two decades has increasingly linked concussions to neurodegenerative conditions including dementia, Alzheimer’s disease, and chronic traumatic encephalopathy (CTE).
How much funding has Oxeia Biopharmaceuticals raised?
Oxeia Biopharmaceuticals has raised $1.4M across 1 round on record. The most recent is an undisclosed round of $1.4M announced in Apr 2026.
When did Oxeia Biopharmaceuticals last raise funding?
Oxeia Biopharmaceuticals' most recent funding round on record is an undisclosed round of $1.4M, announced in Apr 2026.
Who founded Oxeia Biopharmaceuticals?
FundedIQ lists Michael S (Founder) at Oxeia Biopharmaceuticals.
Where is Oxeia Biopharmaceuticals headquartered?
Oxeia Biopharmaceuticals is based in San Diego, California, United States.
How many employees does Oxeia Biopharmaceuticals have?
Oxeia Biopharmaceuticals is in the 11-50 employee band.
How does Oxeia Biopharmaceuticals' funding compare to other Biotechnology startups?
Oxeia Biopharmaceuticals' latest round of $1.4M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Oxeia Biopharmaceuticals Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Oxeia Biopharmaceuticals is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.